Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients

Thorax

Volumn 54, Issue 12, 1999, Pages 1075-1082

  Hood, Pauline P ^a   Cotter, Timothy P ^a   Costello, John F ^a   Sampson, Anthony P ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Corticosteroids; Leukotrienes

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHOCONSTRICTING AGENT; CALCIUM IONOPHORE; CHEMOATTRACTANT; CHROMONE DERIVATIVE; CORTICOSTEROID; GLUCOCORTICOID; LEUKOTRIENE; METHYLPREDNISOLONE; PEPTIDOLEUKOTRIENE; THEOPHYLLINE;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOASSAY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; LUNG LAVAGE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032701357     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.12.1075     Document Type: Article

References (37)

1. Hay DWP, Torphy TJ, Undem BJ. Cysteinyl leukotrienes in asthma: Old mediators up to new tricks. TIPS 1995;16:301-9.
2. 4 and granulocytic infiltration into asthmatic airways. Lancet 1993;341:989-90.
3. 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 1990;142:112-9.
4. 4 after allergen challenge and in acute asthma and allergic rhinitis. Lancet 1989;i:584-8.
5. Holgate ST, Bradding P, Sampson AP. Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy. J Allergy Clin Immunol 1996;98:1-13.
6. Leff AR, Busse WW, Pearlman D, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998;339:147-52.
7. 4 in normal and in asthmatic subjects. Am J Respir Crit Care Med 1997;155:1789-92.
8. 4 and asthma. Thorax 1996;51-1171-3.
9. Peers SH, Flower RJ. The role of lipocortin in corticosteroid actions. Am Rev Respir Dis 1990;141:S18-21.
10. Sebaldt RJ, Sheller JR, Oates JA, et al. Inhibition of eicosanoid synthesis by glucocorticoids. Proc Natl Acad Sci USA 1990;87:6974-8.
11. Manso G, Baker AJ, Taylor IK, et al. In vivo and in vitro effects of glucocorticoids on arachidonic acid metabolism and monocyte function in nonasthmatic humans. Eur Respir J 1992;5:712-6.
12. 4 excretion. Ant Rev Respir Dis 1993;147:1472-6.
13. Dworski R, Fitzgerald GA, Oates JA, et al. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;149:953-9.
14. Vachier I, Chavis C, Godard P, et al. Effect of non-inhaled glucocorticoids on neutrophils and monocytes eicosanoid production in asthmatic patients. Eur Respir J 1995;8:187s.
15. Storr J, Barrell E, Barry W, et al. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet 1987;i: 879-82.
16. Littenberg B, Gluck EH. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med 1986;314:150-2.
17. 1. J Allergy Clin Immunol 1994;94:870-81.
18. Restrick LJ, Sampson AP, Piper PJ, et al. Inulin as a marker of dilution of bronchoalveolar lavage in asthmatic and normal subjects. Am J Respir Crit Care Med 1995;151:1211-7.
19. Sampson AP, Thomas RU, Costello JF, et al. Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects. Br J Clin Pharmacol 1992;33:423-30.
20. 4 generation by bronchoalveolar lavage cells in asthma. Thorax 1995;50:67-73.
21. Bruijnzeel PL, Virchow JC, Rihs S, et al. Lack of increased numbers of low-density eosinophils in the circulation of asthmatic individuals. Clin Exp Allergy 1993;23:261-9.
22. 4 in response to soluble agonists. J Immunol 1991;147:3855-61.
23. 4. Proc Natl Acad Sci USA 1993;80:7626-30.
24. 4 by purified human neurophils. J Pharmacol Exp Ther 1989;250:598-605.
25. Peters-Golden M, Thebert P. Inhibition by methylprednisolone of zyrnosan-induced leukotriene synthesis in alveolar macrophages. Am Rev Respir Dis 1987;135:1020-6.
26. Baher MS, Eschenbacher WL, Peters-Golden M. Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects. Am Rev Respir Dis 1988;138:1134-12.
27. Peters SP, Naclerio RM, Schleimer RP, et al. The pharmacologic control of mediator release fron human basophils and mast cells. Respiration 1986;50(Suppl 2):116-22.
28. Seymour ML, Aberg D, Riise G, et al. Seasonal allergen exposure increases expression of leukotriene pathway enzymes and induces eosinophil influx in bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 1998;101:711 (abstract).
29. Barnes PJ, Adcock I, Anti-inflammatory actions of steroids: Molecular mechanisms. TIPS 1993;14:436-41.
30. Kennedy BP, Dichl RE, Boic Y, et al. Gene characterization and promoter analysis of human 5-lipoxygenase-activating protein (FLAP). J Biol Chem 1991;226:8511-6.
31. Hoshiko S, Radmark O, Samuelsson B. Characterization of the human 5-lipoxygenase promoter. Proc Natl Acad Sci USA 1990;87:9073-7.
32. Goppelt-Struebe M, Schaefer D, Habenicht AJR. Differential regulation of cyclooxygenase-2 and 5-lipoxygenase-activating protein (FLAP) expression by glucocorticoids in monocytic cells. Br J Pharmacol 1997;122:619-24.
33. Pouliot M, McDonald PP, Borgeat P, et al. Granulocyte macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J Exp Med 1994;179: 1225-32.
34. Riddick CA, Ring WI, Baker JR, et al. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 link monocytes and THP-1 cells. Eur J Biochem 1997;246:112-8.
35. Cowburn AS, Holgate ST, Sampson AP. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils. J Immunol 1990;163:456-65.
36. De Caterina R, Sicari R, Giannessi D, et al. Macrophage-specific cicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J Appl Physiol 1993;75: 2368-75.
37. 4 secretion by fluticasone propionate in exogenously activated human eosinophils. Am J Respir Crit Care Med 1999;159:1903-9.